Work productivity among patients with metastatic breast cancer in the United States.

Sneha DurgapalKent A HansonSamantha K KuroskySharon KautzSteve SisonChristina Cool

Published in: Expert review of pharmacoeconomics & outcomes research (2022)

Regimen-based disease progression is associated with increased use of STD and LTD. Patients with a 1 L regimen of chemotherapy have significantly higher odds of using STD or LTD than patients using 1 L CDK4/6i.

Keyphrases

metastatic breast cancer
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
climate change
cell proliferation